| Primary |
| Haemolysis |
50.0% |
| Haemorrhage |
25.0% |
| Hepatic Failure |
25.0% |
|
| Drug Ineffective |
20.0% |
| Medication Error |
20.0% |
| Mitochondrial Dna Depletion |
20.0% |
| No Therapeutic Response |
20.0% |
| Platelet Count Increased |
20.0% |
|
| Secondary |
| Thrombosis |
18.2% |
| Abdominal Pain |
9.1% |
| Angioplasty |
9.1% |
| Breast Cancer Metastatic |
9.1% |
| Clostridium Difficile Colitis |
9.1% |
| Confusional State |
9.1% |
| Coronary Artery Disease |
9.1% |
| Electrolyte Substitution Therapy |
9.1% |
| Infection Prophylaxis |
9.1% |
| Pain |
9.1% |
|
| Thrombosis |
50.0% |
| Victim Of Abuse |
50.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.0% |
| Drug Use For Unknown Indication |
18.6% |
| Prophylaxis |
7.0% |
| Hypertension |
5.5% |
| Pain |
5.0% |
| Febrile Neutropenia |
3.0% |
| Atrial Fibrillation |
2.8% |
| Pseudomonas Infection |
2.2% |
| Constipation |
2.1% |
| Prostate Cancer |
2.1% |
| Proteus Infection |
2.1% |
| Rash |
2.1% |
| Nausea |
1.6% |
| Cystic Fibrosis |
1.5% |
| Adenocarcinoma |
1.4% |
| Foetal Exposure During Pregnancy |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Acute Myeloid Leukaemia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Anxiety |
0.9% |
|
| Weight Decreased |
30.8% |
| Vomiting |
13.2% |
| Tooth Extraction |
9.9% |
| Gastrointestinal Perforation |
4.4% |
| Thrombocytopenia |
4.4% |
| Ventricular Fibrillation |
4.4% |
| Renal Tubular Necrosis |
3.3% |
| Twin Pregnancy |
3.3% |
| Aplasia Pure Red Cell |
2.2% |
| Death |
2.2% |
| Diarrhoea |
2.2% |
| Haemoglobin Decreased |
2.2% |
| Hepatic Neoplasm Malignant |
2.2% |
| Localised Infection |
2.2% |
| Overdose |
2.2% |
| Pneumonia Bacterial |
2.2% |
| Pulmonary Embolism |
2.2% |
| Respiratory Distress |
2.2% |
| Respiratory Failure |
2.2% |
| Septic Shock |
2.2% |
|
